ArQule, Inc. (ARQL) financial statements (2021 and earlier)

Company profile

Business Address ONE WALL STREET
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments125179921001004643
Cash and cash equivalents421091819161711
Short-term investments83707480842932
Receivables1136631
Prepaid expense211111 
Other undisclosed current assets      1
Total current assets:128182971061075045
Noncurrent Assets
Property, plant and equipment0000000
Long-term investments and receivables494  5  
Long-term investments494  5  
Other noncurrent assets0000000
Other undisclosed noncurrent assets311    
Total noncurrent assets:52520500
TOTAL ASSETS:180187981071135045
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:101012131188
Accounts payable1111100
Accrued liabilities1111111
Employee-related liabilities2212211
Other undisclosed accounts payable and accrued liabilities6688766
Debt64320  
Other undisclosed current liabilities 11    
Total current liabilities:151515151188
Noncurrent Liabilities
Long-term debt and lease obligation12111213141515
Long-term debt, excluding current maturities10111213141515
Operating lease, liability2  
Liabilities, other than long-term debt      4
Derivative instruments and hedges, liabilities      4
Other undisclosed noncurrent liabilities 00    
Total noncurrent liabilities:12111213141518
Total liabilities:27262728252327
Temporary equity, carrying amount      9
Stockholders' equity
Stockholders' equity attributable to parent1531627179872710
Common stock1111111
Additional paid in capital730728628626626560548
Accumulated other comprehensive income (loss)000(0)(0)(0)(0)
Accumulated deficit(578)(567)(558)(548)(540)(534)(539)
Total stockholders' equity:1531627179872710
TOTAL LIABILITIES AND EQUITY:180187981071135045

Income statement (P&L) ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Gross profit:001 514 
Operating expenses(11)(9)(12)(12)(11)(9)(8)
Other undisclosed operating income   3  4
Operating income (loss):(11)(9)(10)(9)(6)5(4)
Nonoperating income (expense)111 11(2)
Investment income, nonoperating111 100
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(11)(9)(10)(9)(6)5(7)
Other undisclosed income from continuing operations before income taxes   1   
Net income (loss):(11)(9)(10)(8)(6)5(7)
Other undisclosed net income (loss) attributable to parent   (1) 00
Net income (loss) available to common stockholders, diluted:(11)(9)(10)(8)(6)5(7)

Comprehensive Income ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net income (loss):(11)(9)(10)(8)(6)5(7)
Comprehensive income (loss):(11)(9)(10)(8)(6)5(7)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent000(1)(0)00
Comprehensive income (loss), net of tax, attributable to parent:(11)(9)(10)(9)(6)5(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: